Safety and Immunogenicity of DNA Prime and Modified Vaccinia Ankara Virus-HIV Subtype C Vaccine Boost in Healthy Adults

作者
Peter Hayes,Jill Gilmour,Andrea von Lieven,Dilbinder K. Gill,Lorna Clark,Jakub Kopycinski,Hannah M. Cheeseman,Amy W. Chung,Galit Alter,Len Dally,Devika Zachariah,Angela Lombardo,James Ackland,Eddy Sayeed,Akil Jackson,Marta Boffito,Brian Gazzard,Patricia Fast,Josephine H. Cox,Dagna Laufer
出处
期刊:Clinical and Vaccine Immunology [American Society for Microbiology]
卷期号:20 (3): 397-408 被引量:28
标识
DOI:10.1128/cvi.00637-12
摘要

A randomized, double-blind, placebo-controlled phase I trial was conducted in 32 HIV-uninfected healthy volunteers to assess the safety and immunogenicity of 3 doses of DNA vaccine (Advax) plus 1 dose of recombinant modified vaccinia virus Ankara (MVA) (TBC-M4) or 3 doses of TBC-M4 alone (groups A and B, respectively). Both vaccine regimens were found to be safe and well tolerated. Gamma interferon (IFN-γ) enzyme-linked immunosorbent spot (ELISPOT) assay responses were detected in 1/10 (10%) individuals in group A after three Advax primes and in 9/9 individuals (100%) after the MVA boost. In group B, IFN-γ ELISPOT responses were detected in 6/12 (50%) and 7/11 (64%) individuals after the second and third MVA vaccinations, respectively. Responses to all vaccine components, but predominantly to Env, were seen. The breadth and magnitude of the T cell response and viral inhibition were greater in group A than in group B, indicating that the quality of the T-cell response was enhanced by the DNA prime. Intracellular cytokine staining indicated that the T-cell responses were polyfunctional but were skewed toward Env with a CD4(+) phenotype. At 2 weeks after the last vaccination, HIV-specific antibody responses were detected in all (100%) group B and 1/11 (9.1%) group A vaccinees. Vaccinia virus-specific responses were detected in all (100%) group B and 2/11 (18.2%) group A vaccinees. In conclusion, HIV-specific T-cell responses were seen in the majority of volunteers in groups A and B but with a trend toward greater quality of the T-cell response in group A. Antibody responses were better in group B than in group A.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
12345发布了新的文献求助10
2秒前
共享精神的应助被搞怪的乐荷采纳,获得10
2秒前
3秒前
3秒前
3秒前
kk子的应助被Glllll采纳,获得20
3秒前
浮云客发布了新的文献求助10
3秒前
赤道永恒完成签到,获得积分10
5秒前
5秒前
6秒前
6秒前
霍霍发顶刊完成签到 ,获得积分10
6秒前
大个的应助被科研通管家采纳,获得10
6秒前
6秒前
6秒前
Jasper的应助被葡萄小伊ovo采纳,获得10
6秒前
6秒前
852的应助被葡萄小伊ovo采纳,获得10
6秒前
茉莉雨的应助被科研通管家采纳,获得10
7秒前
天天快乐的应助被葡萄小伊ovo采纳,获得10
7秒前
Orange的应助被葡萄小伊ovo采纳,获得10
7秒前
7秒前
Jasper的应助被WangXingQuan采纳,获得10
7秒前
脑洞疼的应助被科研通管家采纳,获得10
7秒前
Akim的应助被科研通管家采纳,获得10
7秒前
zhuyulong关注了科研通微信公众号
7秒前
Jun的应助被科研通管家采纳,获得10
7秒前
7秒前
半夏完成签到,获得积分10
7秒前
Roy007发布了新的文献求助10
7秒前
7秒前
JamesPei的应助被科研通管家采纳,获得10
7秒前
邓六一完成签到,获得积分10
7秒前
烟花的应助被科研通管家采纳,获得10
8秒前
Jun的应助被科研通管家采纳,获得10
8秒前
8秒前
丘比特的应助被科研通管家采纳,获得10
8秒前
外向幻桃完成签到,获得积分10
8秒前
所所的应助被科研通管家采纳,获得10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183601
求助须知:如何正确求助?哪些是违规求助? 9572875
关于积分的说明 21827816
捐赠科研通 7780716
什么是DOI,文献DOI怎么找? 3434031
关于科研通互助平台的介绍 2558197
邀请新用户注册赠送积分活动 2480485